20160128 EGA Regulatory and Scientific Affairs Conferenc

Impact of COVID-19 on active ingredient and medicines manufacturing and supplies in Europe

18 February 2020


Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

Read more

The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe

7 February 2020


Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Read more

Time to modernise the EU pharmaceutical regulatory framework to deliver on access

30 January 2020

To maintain its leadership in pharmaceutical regulatory science, the EU […]


Smart Pharmacovigilance Essential for Patient Safety

29 January 2020

Medicines are developed and manufactured to help patients so, it […]

Read more

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs

16 January 2020


Hanan Sboul takes over the position of IGBA Chair

7 January 2020


Better access to medicines in Bulgaria prioritised by Medicines for Europe President

16 December 2019

Christoph Stoller, the President of Medicines for Europe, led an […]

Read more

Key topics: medicines shortages

9 December 2019

Read more

Subscribe to our newsletter